|
ABCB7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.566000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99121999999718E-05 |
| Normal-vs-Stage2 |
2.609400E-01 |
| Normal-vs-Stage3 |
4.878200E-01 |
| Normal-vs-Stage4 |
2.255400E-01 |
| Stage1-vs-Stage2 |
2.224400E-01 |
| Stage1-vs-Stage3 |
5.964900E-04 |
| Stage1-vs-Stage4 |
5.165900E-04 |
| Stage2-vs-Stage3 |
1.733440E-01 |
| Stage2-vs-Stage4 |
8.573500E-02 |
| Stage3-vs-Stage4 |
5.938200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.975720E-02 |
| Normal-vs-AfricanAmerican |
1.924170E-01 |
| Normal-vs-Asian |
5.653400E-01 |
| Caucasian-vs-AfricanAmerican |
1.016470E-02 |
| Caucasian-vs-Asian |
7.513600E-01 |
| AfricanAmerican-vs-Asian |
2.020200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.215800E-02 |
| Normal-vs-Female |
2.708000E-01 |
| Male-vs-Female |
4.833200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.602000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.632250E-02 |
| Normal-vs-Age(61-80Yrs) |
1.712350E-01 |
| Normal-vs-Age(81-100Yrs) |
2.431800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.790000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.262000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.702800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.872600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.833500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.827900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.709900E-02 |
| Normal-vs-Grade 2 |
1.80695999999481E-05 |
| Normal-vs-Grade 3 |
6.573400E-01 |
| Normal-vs-Grade 4 |
1.265830E-02 |
| Grade 1-vs-Grade 2 |
6.059400E-01 |
| Grade 1-vs-Grade 3 |
1.015570E-01 |
| Grade 1-vs-Grade 4 |
1.029540E-02 |
| Grade 2-vs-Grade 3 |
9.236500E-04 |
| Grade 2-vs-Grade 4 |
2.10659999999585E-06 |
| Grade 3-vs-Grade 4 |
5.057100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.24320000352662E-08 |
| Normal-vs-ccB subtype |
6.621800E-01 |
| ccA subtype-vs-ccB subtype |
3.90990000043168E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.753500E-02 |
| Normal-vs-N1 |
6.895600E-02 |
| N0-vs-N1 |
1.290190E-02 |
|
|
